E-QURE Corp EQUR:OTCQB

RT Quote | Exchange | USD
Last | 02/24/21 EST
0.07UNCH (UNCH)
52 week range
0.00 - 0.16

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.07
  • 52 Week High0.16
  • 52 Week High Date04/15/20
  • 52 Week Low0.00
  • 52 Week Low Date01/12/21
  • Market Cap2.42M
  • Shares Out34.55M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta3.56
  • 1 Year % Change23.89

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-6.11
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-430,780.00
  • ROE (MRQ)-64,210.34%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-77.30%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest E-QURE Corp News

There is no recent news for this security.

Latest EQUR News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
E-Qure Corp. owns intellectual property (IP) of technology of wound healing device. The IP assets, including the wound healing device, are designed for wound treatment incorporating Bioelectrical Signal Therapy (BST Device). The BST Device implements electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The BST Device, using electrodes affixed around the opposing sides of the wound, emits an electrical field around the...
Ron Weissberg
Chairman
Ohad Goren
Chief Executive Officer
Gal Peleg
Chief Financial Officer
Itsik Ben Yesha
Chief Technology Officer
Address
20 W 64th St Apt 39g
New York, NY
10023-7160
United States